The present study compared palmatine to metformin and glimepiride in a type 2 diabetes model on ADME analysis and insulin resistance via the PI3K/AKT/GLUT4 signaling pathway: in vitro, in vivo, ex vivo, and in silico molecular docking. Here, AKT1 is linked to type 2 diabetes mellitus.